5.80% 0.94

Arcutis Biotherapeutics Inc (ARQT)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ARQT? Forum Prognose

Finanzdaten der Arcutis Biotherapeutics Inc-Aktie (ARQT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	23.78% 81.50	65.85	71.36	44.76	30.86
Cost Of Revenue	15.15% 7.492	8.83	6.905	5.503	3.464
Gross Profit	29.81% 74.01	57.02	64.45	39.25	27.39
Operating Expenses	8.68% 88.62	81.55	72.09	78.32	77.47
Benefits Costs and Expenses	6.35% 96.11	90.38	78.99	83.82	80.94
Costs And Expenses	6.35% 96.11	90.38	78.99	83.82	80.94
Operating Income/Loss	40.43% -14.61	-24.53	-7.632	-39.07	-50.08
Income/Loss From Continuing Operations Before Tax	41.70% -14.61	-25.06	-7.632	-39.07	-52.33
Income Tax Expense/Benefit	22.58% 0.342	0.279	0.323	-	-
Income/Loss From Continuing Operations After Tax	36.61% -15.89	-25.06	-10.79	-41.54	-52.33
Net Income/Loss	36.61% -15.89	-25.06	-10.79	-41.54	-52.33
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.76% 127.00	126.04	1.3299	124.30	123.48
Diluted Average Shares	0.76% 127.00	126.04	1.3299	124.30	123.48
Basic Earnings Per Share	35.00% -0.13	-0.20	-0.08	-0.33	-0.42
Diluted Earnings Per Share	35.00% -0.13	-0.20	-0.08	-0.33	-0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.64

1.40%

GMAB

$27.54

0.58%

SMMT

$25.98

9.16%

BNTX

$112.46

8.66%

INSM

$145.10

1.80%

ONC

$341.80

7.24%